Your browser doesn't support javascript.
loading
Improvement of the understanding of blood donors with human T-cell leukaemia virus type 1 using a new information booklet.
Nakamura, Hitomi; Sagara, Yasuko; Yamamoto, Midori; Utsunomiya, Atae; Watanabe, Toshiki; Satake, Masahiro; Irita, Kazuo.
  • Nakamura H; Department of Quality, Japanese Red Cross Kyushu Block Blood Centre, Chikushino, Japan.
  • Sagara Y; Department of Quality, Japanese Red Cross Kyushu Block Blood Centre, Chikushino, Japan.
  • Yamamoto M; Department of Quality, Japanese Red Cross Kyushu Block Blood Centre, Chikushino, Japan.
  • Utsunomiya A; Department of Haematology, Imamura General Hospital, Kagoshima, Japan.
  • Watanabe T; Department of Haematology and Oncology, Research Hospital, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Satake M; Department of Practical Management of Medical Information, St. Marianna University Graduate School of Medicine, Kawasaki, Japan.
  • Irita K; Central Blood Institute, Blood Service Headquarters, Japanese Red Cross Society, Tokyo, Japan.
Transfus Med ; 31(6): 481-487, 2021 Dec.
Article en En | MEDLINE | ID: mdl-34549482
ABSTRACT

BACKGROUND:

Human T-cell leukaemia virus type 1 (HTLV-1) tests have been mandated in Japan since 1986, and notification of HTLV-1-seropositive donors started in 1999. However, donor knowledge and response to notification has not been assessed. STUDY DESIGN AND

METHODS:

A questionnaire survey was conducted among blood donors notified of HTLV-1 seropositivity regarding their knowledge of HTLV-1 and unmet information needs. To reduce anxiety among notified individuals and raise awareness of their infection status, we created a booklet containing information that would be useful for these individuals without causing unnecessary anxiety while also requesting that they refrain from donating blood in the future.

RESULTS:

A questionnaire survey conducted before the distribution of a new booklet revealed that 15.0% of respondents donated blood again despite receiving an HTLV-1-seropositive notification at the previous donation. While 62.2% of respondents reacted to the notification favourably, 40.2% expressed anxiety and 32.5% requested information on related diseases and medical institutions for consultation. In the secondary survey after distribution of the new booklet, 87.9% of respondents reported that the information was comprehensible, and an increase in consultations of medical institutions by notification recipients was observed. Furthermore, no re-visiting donors were observed among the HTLV-1-seropositive recipients who were notified using the new information booklet.

CONCLUSION:

The new information booklet provided enlightenment on HTLV-1 infection and facilitated the consultation of medical institutions by seropositive donors, leading to an improvement in the health-related quality of life of seropositive blood donors and the safety of blood products.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Virus Linfotrópico T Tipo 1 Humano / Infecciones por HTLV-I / Infecciones por HTLV-II / Leucemia de Células T Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Virus Linfotrópico T Tipo 1 Humano / Infecciones por HTLV-I / Infecciones por HTLV-II / Leucemia de Células T Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article